Atorvastatin Calcium Hydrate/Metformin Hydrochloride

阿托伐他汀钙/盐酸二甲双胍

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAtorvastatin Calcium Hydrate/Metformin Hydrochloride
Drug Alias NameAtorvastatin/Metformin盐酸二甲双胍/阿托伐他汀钙Metformin/AtorvastatinAtorvastatin Calcium Hydrate and Metformin HydrochlorideMetformin Hydrochloride and Atorvastatin Calcium Hydrate +[6] 
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1HMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasDiabetes Mellitus, Type 2
Global Approved IndicationsHyperlipidemiasDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2018/05/01
Country/TerritorySouth Korea
CombinationsYes Metformin HydrochlorideAtorvastatin Calcium Hydrate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHK inno.N CorporationDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHK inno.N Corporation
Active IndicationsHyperlipidemiasDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeC10BA
Related LinksN/A